Wednesday, June 22, 2011

Infolep Choice of new (e) publications on leprosy

Leprosy Mailing List –  April 9th, 2011 
Ref:  Infolep Choice of new (e) publications on leprosy 2011 03 29    
From: Jiske Erlings, Amsterdam, The Netherlands


Dear Salvatore,
Below you will find a selection of new publications on leprosy.  Please contact me for full text versions.  Do you have publications on leprosy to share? Please let me know! 
Please feel free to forward this service to others who might be interested.
With kind regards,
Jiske Erlings
Infolep Leprosy Information Services
Postbus / P.O. Box 95005
1090 HA Amsterdam
The Netherlands
Tel: +31 20 5950530
E-mail: 
J.Erlings(at)Leprastichting.NLWeb: www.leprosy-information.org


 Articles

1. Bhalerao DS, Kinikar AG, Roushani SB, Franklin VX.
Shewanelia putrefaciens: a rare microbial agent associated with a non-healing ulcer in a leprosy patient. Indian J Lepr. 2010;82(4):205-7.
2. Cardozo AV, Deps P, Antunes JM, Andr A de BF, Rosa PS. Mycobacterium leprae in ocular tissues: Histopathological findings in experimental leprosy. Indian J Dermatol Venereol Leprol. 2011;77(2):252-3.
Free full text online: http://www.ijdvl.com/text.asp?2011/77/2/252/77490

3. 
Contin LA, Alves CJ, Fogagnolo L, Nassif PW, Barreto JA, Lauris JR, et al. Use of the ML-Flow test as a tool in classifying and treating leprosy. Anais brasileiros de dermatologia. 2011;86(1):91-5.
Free full text online: http://www.leprosy-information.org/resource/use-ml-flow-test-tool-classifying-and-treating-leprosy

4. 
Daniel E, Rao PS, ffytche TJ, Courtright P.
Ocular hypotension and hypotony in multibacillary leprosy patients; at diagnosis, during and after completion of multidrug therapy. Indian J Lepr. 2010;82(4):181-8.
5. Jadhav R, Suneetha L, Kamble R, Shinde V, Devi K, Chaduvula M, et al. Analysis of Antibody and Cytokine Markers for Leprosy Nerve Damage and Reactions in the INFIR Cohort in India. PLoS Negl Trop Dis. 2011;5(3):e977.
6. Jaiswal AK, Subbarao NT.
Bilateral lagophthalmos in leprosy: is it a rare phenomenon? Indian J Lepr. 2010;82(4):201-3.
Free full text online: http://www.leprosy-information.org/resource/bilateral-lagophthalmos-leprosy-it-rare-phenomenon

7. Kamal R, Natrajan M, Katoch K, Katoch VM.
Evaluation of diagnostic role of in situ PCR on slit-skin smears in pediatric leprosy. Indian J Lepr. 2010;82(4):195-200.
8. Kobe Y, Setoguchi D, Kitamura N. Dapsone-induced agranulocytosis leading to perianal abscess and death: a case report. Journal of medical case reports. 2011;5(1):107.
9. Lanza FM, Lana FC.
Decentralization of leprosy control actions in the micro-region of Almenara, State of Minas Gerais. Rev Lat Am Enfermagem. 2011;19(1):187-94.
Free full text online: http://www.leprosy-information.org/resource/decentralization-leprosy-control-actions-micro-region-almenara-state-minas-gerais

10. 
Lasry-Levy E, Hietaharju A, Pai V, Ganapati R, Rice AS, Haanpää M, et al. Neuropathic pain and psychological morbidity in patients with treated leprosy: a cross-sectional prevalence study in mumbai. PLoS Negl Trop Dis. 2011;5(3):e981.
Free full text online: http://www.leprosy-information.org/resource/neuropathic-pain-and-psychological-morbidity-patients-treated-leprosy-cross-sectional-preva11. Mahajan VK, Chauhan PS, Sharma NL, Sharma AL, Mehta KI. Severe vasculonecrotic erythema nodosum leprosum following thalidomide withdrawal without tapering doses: do we have something unusual? Braz J Infect Dis. 2011;15(1):90-1.
12. Malik AN, Morris RW, ffytche TJ. The prevalence of ocular complications in leprosy patients seen in the United Kingdom over a period of 21 years. Eye (London, England). 2011.
13. Mendiratta V, Jain A, Chander R, Khan A, Barara M. A nine-year clinico-epidemiological study of Histoid Hansen in India. J Infect Dev Ctries. 2011;5(2):128-31.
Free full text online: http://www.leprosy-information.org/resource/nine-year-clinico-epidemiological-study-histoid-hansen-india
14. Penna ML, Temporão JG, de Grossi MA, Penna GO. Leprosy control: knowledge shall not be neglected. Journal of epidemiology and community health. 2011.
15. Prasad PV, Kaviarasan PK.
Leprosy therapy, past and present: can we hope to eliminate it? Indian J Dermatol. 2010;55(4):316-24.
16. Rastogi R, Budhiraja V, Ramesh Babu CS, Madan M, Krishna A, Asthana AK. Micropathological changes in the sub-epidermal zone of normal appearing skin in leprosy. Rom J Morphol Embryol. 2011;52(1):165-9.
17. Sales AM, Ponce de Leon A, Düppre NC, Hacker MA, Nery JA, Sarno EN, et al.
Leprosy among Patient Contacts: A Multilevel Study of Risk Factors. PLoS Negl Trop Dis. 2011;5(3):e1013.
18. Stevelink SA, van Brakel WH, Augustine V. Stigma and social participation in Southern India: Differences and commonalities among persons affected by leprosy and persons living with HIV/AIDS. Psychology, health & medicine. 2011:1-13.
19. Su T-, Wu L-, Lin C-. The prevalence of dementia and depression in Taiwanese institutionalized leprosy patients, and the effectiveness evaluation of reminiscence therapy-a longitudinal, single-blind, randomized control study. International journal of geriatric psychiatry. 2011.
20. Vara N, Agrawal M, Marfatia Y. Leprosy beyond MDT: study of follow-up of 100 released from treatment cases. Indian J Lepr. 2010;82(4):189-94.
Free full text online: http://www.leprosy-information.org/resource/leprosy-beyond-mdt-study-follow-100-released-treatment-cases

No comments: